Lovisa returns to pre-COVID levels on European acquisition
Por um escritor misterioso
Descrição
On the back of a European acquisition, Jewellery retailer Lovisa (ASX: LOV) has seen its shares bounce back to levels not seen since the COVID-19 pandemic slamm
N-CSR
Poster abstracts, 2023
Reducing societal impacts of SARS-CoV-2 interventions through
Harnessing Nanovaccines for Effective Immunization─A Special
Decellularized diseased tissues: current state‐of‐the‐art and
Mapping the nucleolar proteome reveals a spatiotemporal
)
Lovisa returns to pre-COVID levels on European acquisition
Economic Bulletin Issue 2, 2021
Acta Paediatrica: Vol 110, No 5
Biomedicines, Free Full-Text
Plasma proteins elevated in severe asthma despite oral steroid use
Dysregulation of the Kynurenine Pathway, Cytokine Expression
The gut virome: A new microbiome component in health and disease
Economic Bulletin Issue 2, 2021
Development of New Leishmanicidal Compounds via Bioconjugation of
de
por adulto (o preço varia de acordo com o tamanho do grupo)
